AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Bonesupport Holding

Declaration of Voting Results & Voting Rights Announcements May 31, 2022

3016_rns_2022-05-31_2e94f0e7-7922-4c35-beff-04edf619fd07.pdf

Declaration of Voting Results & Voting Rights Announcements

Open in Viewer

Opens in native device viewer

Change in number of shares and votes in BONESUPPORT HOLDING AB (publ)

BONESUPPORT HOLDING AB (publ), a leading company in orthobiologics for the management of bone injuries, today announced a change in the number of shares and votes.

During May, the number of shares and votes in BONESUPPORT HOLDING AB (PUBL) has increased with 5,125 due to the exercise of warrants within the employee stock options program 2012/2022.

As per May 31, 2022, the total number of shares in BONESUPPORT HOLDING AB (publ) amounts to 65,507,647 shares, divided into 64,504,781 ordinary shares with one vote per share and 1,002,866 series C-shares with one-tenth of a vote per share, corresponding to a total of 64,605,067.6 votes.

For more information contact:

BONESUPPORT Holding AB Emil Billbäck, CEO +46 (0) 46 286 53 70

Håkan Johansson, CFO +46 (0) 46 286 53 70 [email protected]

Cord Communications Charlotte Stjerngren +46 (0) 708 76 87 87 [email protected] www.cordcom.se

This information is information that BONESUPPORT Holding AB (publ) is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication at 2022-05-31 12:00 CEST.

About BONESUPPORT™

BONESUPPORT (Nasdaq Stockholm: BONEX) develops and commercializes innovative injectable bio-ceramic bone graft substitutes that remodel to the patient's own bone and have the capability of eluting drugs. BONESUPPORT's bone graft substitutes are based on the patented technology platform CERAMENT. The company is conducting several clinical studies to further demonstrate the clinical and health economic benefits its products deliver. The company is based in Lund, Sweden, and the net sales amounted to SEK 213 million in 2021. Please visit www.bonesupport. com for more information.

BONESUPPORT and CERAMENT are registered trademarks of BONESUPPORT AB.

Press Release 31 May 2022 12:00:00 CEST

Attachments

Change in number of shares and votes in BONESUPPORT HOLDING AB (publ)

Talk to a Data Expert

Have a question? We'll get back to you promptly.